Jeffrey Koenitzer is a Respiratory physician affiliated with Washington University in St. Louis. OpenAlex indexes 45 publications with 1,525 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Barnes Jewish Hospital Plz
Div Im Pulmonary
Saint Louis, MO 631101003
Telephone
314-454-8762Provider last certified this registry record 14 Apr 2021.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- United Therapeutics CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2022–2026 per NIH RePORTER. The latest:
- Microfibril-associated glycoproteins attenuating pulmonary fibrosis
Washington University
FY2026$156,182K08HL159418 - Microfibril-associated glycoproteins attenuating pulmonary fibrosis
Washington University
FY2025$156,182K08HL159418 - Microfibril-associated glycoproteins attenuating pulmonary fibrosis
Washington University
FY2025$75,600K08HL159418
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Latent transforming growth factor binding protein-2 (LTBP2), an IPF biomarker of clinical decline, promotes TGF-beta signaling and lung fibrosis in mice
American Journal of Respiratory Cell and Molecular Biology
2026 - E2F1 Drives Endothelial Arterial Programming in Pulmonary Arterial Hypertension
bioRxiv (Cold Spring Harbor Laboratory)
2026 - Targeting the DNA damage repair protein RAD51 alters fibroblast metabolism and enhances apoptosis in pulmonary fibrosis
bioRxiv (Cold Spring Harbor Laboratory)
2026 - Undocking of an extensive ciliary network induces proteostasis and cell fate switching resulting in severe primary ciliary dyskinesia
Science Translational Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Ley, MD
Washington University in St. Louis
David Gutmann, MD
Washington University in St. Louis
Randall Bateman, MD
Washington University in St. Louis
Victoria Fraser, MD
Washington University in St. Louis
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”